Combined genotypes of ACE and NADPH oxidase p22phox associated with somatic mutation of mtDNA and carotid intima-media thickness in Japanese patients with type 2 diabetes mellitus

Current Therapeutic Research - Clinical and Experimental

Volumn 63, Issue 12, 2002, Pages 842-852

  Piao, Lianshan ^a   Tanaka, Yasushi ^b   Nomiyama, Takashi ^b   Nakajima, Kunihiro ^b   Ogihara, Takeshi ^b   Miwa, Shinnya ^b   Urabe, Takao ^b   Watada, Hirotaka ^b   Kawamori, Ryuzo ^b  

^a Affiliated Hosp of Y U C of M   (China)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; Carotid artery intima media thickness; NADPH (nicotinamide adenine dinucleotide phosphate, reduced form) oxidase p22phox; Oxidative stress; Somatic mitochondrial DNA mutation; Type 2 diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOMATIC MUTATION; THICKNESS;

EID: 0036939915     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(02)80089-3     Document Type: Article

References (23)

1. Yamasaki Y, Kawamori R, Matsushima H, et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia. 1995;38:585-591.
2. Kawamori R. Asymptomatic hyperglycaemia and early atherosclerotic changes. Diabetes Res Clin Pract. 1998;40(Suppl):S35-S42.
3. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
4. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: The Atherosclerosis Risk in Communities (ARC) study. Am J Epidemiol. 2000;151:478-487.
5. Hinokio Y, Suzuki S, Hirai M, et al. Oxidative DNA damage in diabetes mellitus: Its association with diabetic complications. Diabetologia. 1999;42:995-998.
6. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-790.
7. Nomiyama T, Tanaka Y, Hattori N, et al. Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients. Diabetologia. In press.
8. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656-1662.
9. Azumi H, Inoue N, Takeshita S, et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation. 1999;100:1494-1498.
10. Guzik TJ, West NE, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation. 2000;102:1744-1747.
11. Inoue N, Kawashima S, Kanazawa K, et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation. 1998;97:135-137.
12. Ito D, Murata M, Watanabe K, et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke. 2000;31:936-939.
13. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
14. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
15. Viedt C, Soto U, Krieger-Brauer HI, et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: Involvement of P22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol. 2000;20:940-948.
16. The Committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Jpn Diab Soc. 1999;42:385-404.
17. Kogawa K, Nishizawa Y, Hosoi M, et al. Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Diabetes. 1997;46:682-687.
18. Corral-Debrinski M, Horton T, Lott MT, et al. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat Genet. 1992;2:324-329.
19. Hayakawa M, Hattori K, Sugiyama S, Ozawa T. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun. 1992;189:979-985.
20. Liang P, Hughes V, Fukagawa NK. Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: Possible marker of glycemic stress. Diabetes. 1997;46:920-923.
21. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim Biophys Acta. 1995;1271:177-189.
22. Kashiwagi A, Shinozaki K, Nishio Y, et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol. 1999;277:E976-E983.
23. Mannami T, Katsuya T, Baba S, et al. Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: The Suita study. Stroke. 2001;32:1250-1256.